Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authordel Barco Martínez, Ester
dc.contributor.authorFranco Jarava, Clara
dc.contributor.authorVargas Bujan, Mireia
dc.contributor.authorMaiz Elizaran, Nerea
dc.contributor.authorSánchez Durán, Maria Ángeles
dc.contributor.authorAvilés García, Maite
dc.contributor.authorRodó Rodríguez, Carlota
dc.contributor.authorMendoza Cobaleda, Manel
dc.contributor.authorGoya Canino, Maria del Mar
dc.contributor.authorHernández González, Manuel
dc.contributor.authorCarreras Moratonas, Elena
dc.contributor.authorArévalo Martínez, Silvia
dc.date.accessioned2023-03-23T13:10:40Z
dc.date.available2023-03-23T13:10:40Z
dc.date.issued2023-04
dc.identifier.citationdel Barco E, Franco-Jarava C, Vargas M, Maíz N, Arevalo S, Sánchez MÁ, et al. Reference values for interleukin-6 in the amniotic fluid of asymptomatic pregnant women. Acta Obstet Gynecol Scand. 2023 Apr;102(4):480–5.
dc.identifier.issn1600-0412
dc.identifier.urihttps://hdl.handle.net/11351/9233
dc.descriptionAmniocentesis; Interleukin-6; Intra-amniotic inflammation
dc.description.abstractIntroduction Nowadays, proinflammatory factors are considered to play an important role in the pathophysiology of threatened preterm labor or chorioamnionitis. The aim of this study was to establish the normal reference range for interleukin-6 (IL-6) levels in the amniotic fluid and to identify factors which may alter this value. Material and methods Prospective study in a tertiary-level center including asymptomatic pregnant women undergoing amniocentesis for genetic studies from October 2016 to September 2019. IL-6 measurements in amniotic fluid were performed using a fluorescence immunoassay with microfluidic technology (ELLA Proteinsimple, Bio Techne). Maternal history and pregnancy data were also recorded. Results This study included 140 pregnant women. Of those, women who underwent termination of pregnancy were excluded. Therefore, a total of 98 pregnancies were included in the final statistical analysis. The mean gestational age was 21.86 weeks (range: 15–38.7) at the time of amniocentesis, and 38.6 weeks (range: 30.9–41.4) at delivery. No cases of chorioamnionitis were reported. The log10 IL-6 values follow a normal distribution (W = 0.990, p = 0.692). The median, and the 5th, 10th, 90th, and 95th percentiles for IL-6 levels were 573, 105, 130, 1645, and 2260 pg/mL, respectively. The log10 IL-6 values were not affected by gestational age (p = 0.395), maternal age (p = 0.376), body mass index (p = 0.551), ethnicity (p = 0.467), smoking status (p = 0.933), parity (p = 0.557), method of conception (p = 0.322), or diabetes mellitus (p = 0.381). Conclusions The log10 IL-6 values follow a normal distribution. IL-6 values are independent of gestational age, maternal age, body mass index, ethnicity, smoking status, parity and method of conception. Our study provides a normal reference range for IL-6 levels in the amniotic fluid that can be used in future studies. We also observed that normal IL-6 values were higher in the amniotic fluid than in serum.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesActa Obstetricia et Gynecologica Scandinavica;102(4)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectLíquid amniòtic
dc.subjectEmbaràs - Complicacions
dc.subjectInfecció
dc.subject.meshAmniotic Fluid
dc.subject.meshPregnant Women
dc.subject.meshChorioamnionitis
dc.titleReference values for interleukin-6 in the amniotic fluid of asymptomatic pregnant women
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1111/aogs.14524
dc.subject.decslíquido amniótico
dc.subject.decsmujeres embarazadas
dc.subject.decscorioamnionitis
dc.relation.publishversionhttps://doi.org/10.1111/aogs.14524
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Del Barco E, Vargas M, Maíz N, Arevalo S, Sánchez MÁ, Avilés MT, Rodó C, Mendoza M] Unitat de Medicina Materna i Fetal, Servei d’Obstetrícia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Franco-Jarava C, Hernández-González M] Servei d’Immunologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Goya M, Carreras E] Unitat de Medicina Materna i Fetal, Servei d’Obstetrícia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Maternal and Child Health and Development Network (SAMID), Instituto Salud Carlos III, Madrid, Spain
dc.identifier.pmid36906815
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record